查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
南美洲和中美洲放射性示踪剂市场预测至 2030 年 - 区域分析 - 按示踪剂类型、测试类型、应用和最终用户
市场调查报告书
商品编码
1420161

南美洲和中美洲放射性示踪剂市场预测至 2030 年 - 区域分析 - 按示踪剂类型、测试类型、应用和最终用户

South & Central America Radioactive Tracer Market Forecast to 2030 - Regional Analysis - by Tracer Type, Test Type, Application, and End User
出版日期: | 出版商: The Insight Partners | 英文 113 Pages | 订单完成后即时交付

价格

2022年，南美洲和中美洲放射性示踪剂市值为4.7696亿美元，预计2030年将达到16.3433亿美元；预计2022年至2030年CAGR为16.6%。

放射性示踪剂在癌症诊断中的使用推动了南美洲和中美洲放射性示踪剂市场

随着全球癌症病例不断增加，肿瘤学是医疗保健领域显着发展的领域。根据健康指标与评估研究所 (IHME) 的数据，癌症是继心血管疾病之后的第二大死因。随着肿瘤学的显着发展，先进材料和药物在癌症诊断和治疗中的使用激增。基于放射性追踪剂的影像是用于准确诊断癌症类型（例如前列腺癌、妇科癌症和血液传染癌症）的先进诊断方法之一。一旦注射到体内，这些放射性追踪剂就会附着在癌症特定部位，从而准确诊断癌症类型。示踪剂还有助于确定癌症的发展阶段，在大多数情况下实现有效的治疗和更快的恢復。 PET 和 SPECT 属于使用伽玛发射器检测肿瘤的核子造影技术。随着肿瘤的生长，其对 PET 和 SPECT 结合物的吸收随着时间的推移而增加，由于核成像剂的存在而提高了对比度。这进一步导致血液清除，由此可以产生清晰的诊断影像。用于检测癌症的最常用放射性追踪剂是 F-18 氟脱氧葡萄糖 (18F-FDG)，一种类似葡萄糖或糖的化合物。癌细胞高度活跃，比正常细胞需要更多的能量，即额外的葡萄糖。 PET 或 SPECT 等影像设备可侦测 FDG 释放的能量，以建立显示放射性追踪剂在体内位置的影像。这有助于确定癌细胞在患者体内的位置，以便根据癌症的类型和阶段製定治疗方案。因此，在癌症诊断中越来越多地使用放射性示踪剂预计将在预计的时间内推动市场扩张。

南美洲和中美洲放射性示踪剂市场概述

南美洲和中美洲放射性示踪剂市场分为巴西、阿根廷以及南美洲和中美洲其他地区。由于癌症病例数量不断增加、政府措施不断增加以及放射性示踪剂的研发不断增加，预计该地区的市场将会成长。

南美洲和中美洲放射性示踪剂市场收入和 2030 年预测（百万美元）

南美洲和中美洲放射性示踪剂市场细分

南美洲和中美洲放射性示踪剂市场根据示踪剂类型、测试类型、最终用户、应用和国家进行细分。根据示踪剂类型，南美洲和中美洲放射性示踪剂市场分为锝-99m和Tc-97m、碘-131、铁-59、镥-171、氯化铷(Rb-82) 和氨(N -13) , 钪-46、钪-269、 哈西姆-269、柠檬酸镓Ga 67、前列腺特异性膜抗原(PSMA) (Ga-68)、 FDDNP (F-18) 和FDOPA (F-18 )、 磷-32 和铬-51、铊-201、F-18 FDG、F-18 FAPI、Ga-68 FAPI、F-18 PSMA、DOTATOC/DOTANOC/DOTATATE (Ga-68) 等。 2022 年，其他细分市场占据最大市场份额。

根据测试类型，南美洲和中美洲放射性追踪剂市场分为 PET、SPECT 等。 2022 年，PET 细分市场占据最大的市场份额。

根据最终用户，南美洲和中美洲放射性示踪剂市场分为医院和诊所、诊断中心、学术和研究机构等。 2022 年，医院和诊所细分市场占据最大的市场。

根据应用，南美洲和中美洲放射性示踪剂市场分为肿瘤学、肺病学、神经病学、心臟病学等。 2022 年，肿瘤学领域占据最大的市场。

根据国家/地区，南美洲和中美洲放射性示踪剂市场分为巴西、阿根廷以及南美洲和中美洲其他地区。 2022 年，南美洲和中美洲其他地区主导了南美洲和中美洲放射性示踪剂市场。

Rotem Industries Ltd、Invicro LLC、Cardinal Health Inc、纽卡斯尔大学、诺华公司、Curium 和 IBA Radiopharma Solutions 是南美洲和中美洲放射性示踪剂市场的一些领先参与者。

目录

第 1 章：简介

  • Insight Partners 研究报告指南
  • 市场区隔

第 2 章：执行摘要

  • 重要见解

第 3 章：研究方法

  • 覆盖范围
  • 二次研究
  • 初步研究

第 4 章：南美洲和中美洲放射性示踪剂市场 - 主要产业动态

  • 主要市场驱动因素：
    • 慢性病盛行率上升
    • 越来越多地使用核子成像技术
  • 市场限制
    • 放射性示踪剂的保存期限短
    • 核诊断影像程序替代品的可用性
  • 市场机会
    • 新兴经济体的存在与人口的成长
    • 用于标靶治疗的个人化放射性药物的开发
  • 未来的趋势
    • 放射性示踪剂在癌症诊断的应用
  • 影响分析：

第 5 章：放射性示踪剂市场 - 南美洲和中美洲市场分析

  • 放射性示踪剂市场收入，2022 - 2030

第 6 章：南美洲和中美洲放射性示踪剂市场 - 2030 年收入和预测 - 按下示踪剂类型

  • 概述
  • 2022 年及 2030 年放射性示踪剂市场收入份额，依示踪剂类型划分 (%)
  • 锝 99m 和 TC-97m
  • 碘131
  • 铁59
  • 镥- 171
  • RB82和氨N-13
  • 钪46
  • ?-269
  • 哈西姆-269
  • 柠檬酸镓 GA 67
  • PSMA GA68
  • FDDNP (F-18) 和 FDOPA (f-18)
  • 磷 32 和铬 -51
  • 铊201
  • F-18 FDG
  • F-18 FAPI
  • GA 68 FAPI
  • F-18 PSMA
  • DOTATOC/DOTANOC/DOTATATE Ga 68
  • 其他的

第 7 章：南美洲和中美洲放射性示踪剂市场 - 2030 年收入和预测 - 按测试类型

  • 概述
  • 2022 年及 2030 年按测试类型分類的放射性示踪剂市场收入份额 (%)
  • 宠物
  • SPECT
  • 其他的

第 8 章：南美洲和中美洲放射性示踪剂市场 - 2030 年收入和预测 -按应用。

  • 概述
  • 2022 年和 2030 年按应用分類的放射性示踪剂市场收入份额 (%)
  • 肿瘤学
  • 肺部
  • 神经病学
  • 心臟病学
  • 其他的

第 9 章：南美洲和中美洲放射性示踪剂市场 - 收入和 2030 年预测 - 按最终用户

  • 概述
  • 2022 年及 2030 年最终用户放射性示踪剂市场收入份额 (%)
  • 医院和诊所
  • 诊断中心
  • 学术及研究机构
  • 其他的

第 10 章：南美洲和中美洲放射性示踪剂市场 - 国家分析

    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地区

第 11 章：放射性示踪剂市场产业格局

  • 概述
  • 有机发展
    • 概述
  • 无机发展
    • 概述

第 12 章：放射性示踪剂市场，主要公司概况

  • Rotem Industries Ltd
  • Invicro LLC
  • Cardinal Health Inc
  • Newcastle University
  • Novartis AG
  • Curium
  • General Electric Co
  • IBA Radiopharma Solutions

第 13 章：附录

  • 关于我们
  • 专业术语
Product Code: BMIRE00029123

The South & Central America radioactive tracer market was valued at US$ 476.96 million in 2022 and is expected to reach US$ 1,634.33 million by 2030; it is estimated to grow at a CAGR of 16.6% from 2022 to 2030.

Use of Radioactive Tracer in Cancer Diagnosis fuel the South & Central America Radioactive Tracer Market

Oncology is a significantly developing field in the healthcare sector, as cancer cases are increasing worldwide. According to Institute for Health Metrics and Evaluation (IHME), cancer is the second major cause of death after cardiovascular disorders. The use of advanced materials and drugs in the diagnosis and treatment of cancer has surged with prominent developments in oncology. Radioactive tracer-based imaging is one of the advanced diagnostic methods used to accurately diagnose cancer types, such as prostate cancer, gynecological cancer, and blood-borne cancer. Once injected into the body, these radioactive tracers attach to the cancer-specific sites, accurately diagnosing the cancer type. Tracer also helps determine the cancer development stage, enabling effective treatment and faster recovery in most cases. PET and SPECT are among the nuclear imaging techniques that use gamma emitters for detecting tumors. As the tumor grows, its uptake of the PET and SPECT conjugate increases over time, which improves contrast due to the presence of nuclear imaging agents. This further leads to blood clearance due to which clear diagnostic images can be generated. The most commonly used radioactive tracer for detecting cancer is F-18 fluorodeoxyglucose (18F-FDG), a compound similar to glucose or sugar. Cancer cells are highly active and need more energy, i.e., extra glucose, than normal cells. Imaging devices such as PET or SPECT detect this energy released by FDG to create an image showing the location of a radioactive tracer in the body. This helps determine the location of cancerous cells in the patient's body so that the treatment can be tailored according to the type and stage of cancer. Thus, the increasing use of radioactive tracer in cancer diagnostics is anticipated to drive market expansion during the estimated timeframe.

South & Central America Radioactive Tracer Market Overview

The South & Central America radioactive tracer market is segmented into Brazil, Argentina, and the Rest of South & Central America. The market in the region is expected to grow due to the increasing number of cancer cases, growing government initiatives, and rising research and development for radioactive tracer.

South & Central America Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Million)

South & Central America Radioactive Tracer Market Segmentation

The South & Central America radioactive tracer market is segmented based on tracer type, test type, end user, application, and country. Based on tracer type, the South & Central America radioactive tracer market is segmented into technetium-99m & Tc-97m, iodine-131, iron-59, lutetium-171, rubidium (Rb-82) chloride & ammonia (N-13), scandium-46, seaborgium-269, hassium-269, Gallium citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), phosphorus-32 & chromium-51, thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and others. The others segment held the largest market share in 2022.

Based on test type, the South & Central America radioactive tracer market is segmented into PET, SPECT, and others. The PET segment held the largest market share in 2022.

Based on end user, the South & Central America radioactive tracer market is segmented into hospitals & clinics, diagnostic centers, academic & research institutes, and others. The hospitals & clinics segment held the largest market share in 2022.

Based on application, the South & Central America radioactive tracer market is segmented into oncology, pulmonary, neurology, cardiology, and others. The oncology segment held the largest market share in 2022.

Based on country, the South & Central America radioactive tracer market is segmented into Brazil, Argentina, and the Rest of South & Central America. The Rest of South & Central America dominated the South & Central America radioactive tracer market share in 2022.

Rotem Industries Ltd, Invicro LLC, Cardinal Health Inc, Newcastle University, Novartis AG, Curium, and IBA Radiopharma Solutions are some of the leading players operating in the South & Central America radioactive tracer market.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America radioactive tracer market.
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the South & Central America radioactive tracer market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the South & Central America radioactive tracer market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. South & Central America Radioactive Tracer Market - Key Industry Dynamics

  • 4.1 Key Market Drivers:
    • 4.1.1 Rising Prevalence of Chronic Diseases
    • 4.1.2 Increasing Use of Nuclear Imaging Techniques
  • 4.2 Market Restraints
    • 4.2.1 Short Shelf-Life of Radioactive Tracer
    • 4.2.2 Availability of Substitutes to Nuclear Diagnostic Imaging Procedures
  • 4.3 Market Opportunities
    • 4.3.1 Presence of Emerging Economies and Growing Population
    • 4.3.2 Development of Personalized Radiopharmaceuticals for Targeted Therapies
  • 4.4 Future Trends
    • 4.4.1 Use of Radioactive Tracer in Cancer Diagnosis
  • 4.5 Impact Analysis:

5. Radioactive Tracer Market - South & Central America Market Analysis

  • 5.1 Radioactive Tracer Market Revenue (US$ Mn), 2022 - 2030

6. South & Central America Radioactive Tracer Market - Revenue and Forecast to 2030 - by Tracer Types

  • 6.1 Overview
  • 6.2 Radioactive Tracer Market Revenue Share, by Tracer Types 2022 & 2030 (%)
  • 6.3 Technetium 99m and TC-97m
    • 6.3.1 Overview
    • 6.3.2 Technetium 99m and TC-97m: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.4 Iodine 131
    • 6.4.1 Overview
    • 6.4.2 Iodine 131: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.5 Iron 59
    • 6.5.1 Overview
    • 6.5.2 Iron 59: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.6 Lutetium- 171
    • 6.6.1 Overview
    • 6.6.2 Lutetium- 171: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.7 RB82 and ammonia N-13
    • 6.7.1 Overview
    • 6.7.2 RB82 and ammonia N-13: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.8 Scandium 46
    • 6.8.1 Overview
    • 6.8.2 Scandium 46: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.9 Seaborgium-269
    • 6.9.1 Overview
    • 6.9.2 Seaborgium-269: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.10 Hassium -269
    • 6.10.1 Overview
    • 6.10.2 Hassium -269: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.11 Gallium Citrate GA 67
    • 6.11.1 Overview
    • 6.11.2 Gallium Citrate GA 67: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.12 PSMA GA68
    • 6.12.1 Overview
    • 6.12.2 PSMA GA68: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.13 FDDNP (F-18) and FDOPA (f-18)
    • 6.13.1 Overview
    • 6.13.2 FDDNP (F-18) and FDOPA (f-18): Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.14 Phosphorus 32 and Chromium -51
    • 6.14.1 Overview
    • 6.14.2 Phosphorus 32 and Chromium -51: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.15 Thallium-201
    • 6.15.1 Overview
    • 6.15.2 Thallium-201: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.16 F-18 FDG
    • 6.16.1 Overview
    • 6.16.2 F-18 FDG: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.17 F-18 FAPI
    • 6.17.1 Overview
    • 6.17.2 F-18 FAPI: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.18 GA 68 FAPI
    • 6.18.1 Overview
    • 6.18.2 GA 68 FAPI: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.19 F-18 PSMA
    • 6.19.1 Overview
    • 6.19.2 F-18 PSMA: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.20 DOTATOC/DOTANOC/DOTATATE Ga 68
    • 6.20.1 Overview
    • 6.20.2 DOTATOC/DOTANOC/DOTATATE Ga 68: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.21 Others
    • 6.21.1 Overview
    • 6.21.2 Others: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)

7. South & Central America Radioactive Tracer Market - Revenue and Forecast to 2030 - by Test Type

  • 7.1 Overview
  • 7.2 Radioactive Tracer Market Revenue Share, by Test Type 2022 & 2030 (%)
  • 7.3 PET
    • 7.3.1 Overview
    • 7.3.2 PET: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 SPECT
    • 7.4.1 Overview
    • 7.4.2 SPECT: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Others
    • 7.5.1 Overview
    • 7.5.2 Others: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)

8. South & Central America Radioactive Tracer Market - Revenue and Forecast to 2030 - by Application.

  • 8.1 Overview
  • 8.2 Radioactive Tracer Market Revenue Share, by Application 2022 & 2030 (%)
  • 8.3 Oncology
    • 8.3.1 Overview
    • 8.3.2 Oncology: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Pulmonary
    • 8.4.1 Overview
    • 8.4.2 Pulmonary: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Neurology
    • 8.5.1 Overview
    • 8.5.2 Neurology: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Cardiology
    • 8.6.1 Overview
    • 8.6.2 Cardiology: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.7 Others
    • 8.7.1 Overview
    • 8.7.2 Others: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)

9. South & Central America Radioactive Tracer Market - Revenue and Forecast to 2030 - by End User

  • 9.1 Overview
  • 9.2 Radioactive Tracer Market Revenue Share, by End User 2022 & 2030 (%)
  • 9.3 Hospitals and Clinics
    • 9.3.1 Overview
    • 9.3.2 Hospitals and Clinics: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Diagnostic Centers
    • 9.4.1 Overview
    • 9.4.2 Diagnostic Centers: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.5 Academic and Research Institutes
    • 9.5.1 Overview
    • 9.5.2 Academic and Research Institutes: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.6 Others
    • 9.6.1 Overview
    • 9.6.2 Others: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)

10. South & Central America Radioactive Tracer Market - Country Analysis

  • 10.1 South & Central America Radioactive Tracer Market, Revenue and Forecast to 2030
    • 10.1.1 Overview
    • 10.1.2 South & Central America Radioactive Tracer Market by Country
      • 10.1.2.1 Brazil
        • 10.1.2.1.1 Overview
        • 10.1.2.1.2 Brazil Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.1.3 Brazil Radioactive Tracer Market, by Tracer Types
        • 10.1.2.1.4 Brazil Radioactive Tracer Market, by Test Type
        • 10.1.2.1.5 Brazil Radioactive Tracer Market, by Application
        • 10.1.2.1.6 Brazil Radioactive Tracer Market, by End-User
      • 10.1.2.2 Argentina
        • 10.1.2.2.1 Overview
        • 10.1.2.2.2 Argentina Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.2.3 Argentina Radioactive Tracer Market, by Tracer Types
        • 10.1.2.2.4 Argentina Radioactive Tracer Market, by Test Type
        • 10.1.2.2.5 Argentina Radioactive Tracer Market, by Application
        • 10.1.2.2.6 Argentina Radioactive Tracer Market, by End-User
      • 10.1.2.3 Rest of South & Central America
        • 10.1.2.3.1 Overview
        • 10.1.2.3.2 Rest of South & Central America Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.3.3 Rest of South & Central America Radioactive Tracer Market, by Tracer Types
        • 10.1.2.3.4 Rest of South & Central America Radioactive Tracer Market, by Test Type
        • 10.1.2.3.5 Rest of South & Central America Radioactive Tracer Market, by Application
        • 10.1.2.3.6 Rest of South & Central America Radioactive Tracer Market, by End-User

11. Radioactive Tracer Market Industry Landscape

  • 11.1 Overview
  • 11.2 Organic Developments
    • 11.2.1 Overview
  • 11.3 Inorganic Developments
    • 11.3.1 Overview

12. Radioactive Tracer Market, Key Company Profiles

  • 12.1 Rotem Industries Ltd
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Invicro LLC
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Cardinal Health Inc
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Newcastle University
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Novartis AG
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Curium
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 General Electric Co
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 IBA Radiopharma Solutions
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments

13. Appendix

  • 13.1 About Us
  • 13.2 Glossary of Terms

List Of Tables

  • Table 1. South & Central America Radioactive Tracer Market Segmentation
  • Table 2. Principal Radionuclides Used in Radioactive Tracer
  • Table 3. Brazil Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn) - Tracer Types
  • Table 4. Brazil Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn) - Test Type
  • Table 5. Brazil Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn) - Application
  • Table 6. Brazil Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn) - End-User
  • Table 7. Argentina Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn) - Tracer Types
  • Table 8. Argentina Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn) - Test Type
  • Table 9. Argentina Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn) - Application
  • Table 10. Argentina Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn) - End-User
  • Table 11. Rest of South & Central America Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn) - Tracer Types
  • Table 12. Rest of South & Central America Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn) - Test Type
  • Table 13. Rest of South & Central America Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn) - Application
  • Table 14. Rest of South & Central America Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn) - End-User
  • Table 15. Organic Developments Done by Companies
  • Table 16. Inorganic Developments Done by Companies
  • Table 17. Glossary of Terms, South & Central America Radioactive Tracer Market

List Of Figures

  • Figure 1. South & Central America Radioactive Tracer Market Segmentation, By Country
  • Figure 2. South & Central America Radioactive Tracer Market - Key Industry Dynamics
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. South & Central America Radioactive Tracer Market Revenue (US$ Mn), 2022 - 2030
  • Figure 5. South & Central America Radioactive Tracer Market Revenue Share, by Tracer Types 2022 & 2030 (%)
  • Figure 6. Technetium 99m and TC-97m: South & Central America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 7. Iodine 131: South & Central America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Iron 59: South & Central America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Lutetium- 171: South & Central America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. RB82 and ammonia N-13: South & Central America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Scandium 46: South & Central America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Seaborgium-269: South & Central America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Hassium -269: South & Central America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Gallium Citrate GA 67: South & Central America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. PSMA GA68: South & Central America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. FDDNP (F-18) and FDOPA (f-18): South & Central America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Phosphorus 32 and Chromium -51: South & Central America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Thallium-201: South & Central America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. F-18 FDG: South & Central America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. F-18 FAPI: South & Central America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. GA 68 FAPI: South & Central America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. F-18 PSMA: South & Central America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. DOTATOC/DOTANOC/DOTATATE Ga 68: South & Central America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. Others: South & Central America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 25. South & Central America Radioactive Tracer Market Revenue Share, by Test Type 2022 & 2030 (%)
  • Figure 26. PET: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 27. SPECT: South & Central America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 28. Others: South & Central America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 29. South & Central America Radioactive Tracer Market Revenue Share, by Application 2022 & 2030 (%)
  • Figure 30. Oncology: South & Central America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 31. Pulmonary: South & Central America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 32. Neurology: South & Central America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 33. Cardiology: South & Central America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 34. Others: South & Central America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 35. South & Central America Radioactive Tracer Market Revenue Share, by End User 2022 & 2030 (%)
  • Figure 36. Hospitals and Clinics: South & Central America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 37. Diagnostic Centers: South & Central America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 38. Academic and Research Institutes: South & Central America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 39. Others: South & Central America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 40. South & Central America Radioactive Tracer Market, By Geography, 2022 ($Mn)
  • Figure 41. South & Central America Radioactive Tracer Market, By Key Countries, 2022 and 2030 (%)
  • Figure 42. Brazil Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 43. Argentina Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 44. Rest of South & Central America Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn)